GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
87 hedge funds and large institutions have $44.9M invested in GALENA BIOPHARMA INC COM in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
34% more capital invested
Capital invested by funds: $33.6M → $44.9M (+$11.3M)
17% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $3.52M
10% more funds holding
Funds holding: 79 → 87 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$4.8M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.58M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.66M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.13M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$462K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$249K |
| 3 |
Millennium Management
New York
|
-$232K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$208K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$196K |
RXII Hedge Fund Activity: Q1 2015 in Review
87 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q1 2015, worth a combined $44.9M — up 34% from $33.6M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new RXII positions and 10 closed out — a net gain of 8 holders — while 32 added to existing stakes and 18 trimmed.
The largest buyer was Highland Capital Management (Texas), opening a new position worth an estimated $4.8M. The largest seller was Spark Investment Management, exiting entirely with an estimated $462K sold.
- 87 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q1 2015, up from 79 in Q4 2014.
- Funds reported $44.9M of GALENA BIOPHARMA INC COM stock for Q1 2015, up 34% quarter-over-quarter.
- 18 funds opened new GALENA BIOPHARMA INC COM positions in Q1 2015 and 10 closed out, a net change of +8 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q1 2015 was Highland Capital Management (Texas), an estimated $4.8M added.
- The largest GALENA BIOPHARMA INC COM seller in Q1 2015 was Spark Investment Management, an estimated $462K sold.
Based on aggregated 13F filings for Q1 2015.